Nezelof syndrome is an autosomal recessive[6] congenital immunodeficiency condition due to underdevelopment of the thymus. The defect is a type of purine nucleoside phosphorylase deficiency with inactive phosphorylase, this results in an accumulation of deoxy-GTP which inhibits ribonucleotide reductase. Ribonucleotide reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides, thus, DNA replication is inhibited.[medical citation needed]
Nezelof syndrome | |
---|---|
Other names | Thymic dysplasia with normal immunoglobulins[1]: 85 |
Autosomal recessive is the manner in which this condition is inherited | |
Specialty | Immunology |
Symptoms | Hepatosplenomegaly[2] |
Causes | Currently unknown[3] |
Diagnostic method | Blood test[3][4] |
Treatment | Antimicrobial therapy, IV immunoglobulin[5] |
This condition causes severe infections. it is characterized by elevated immunoglobulins that function poorly.[7][8] Other symptoms are:[2]
Genetically speaking, Nezelof syndrome is autosomal recessive. the condition is thought to be a variation of severe combined immunodeficiency (SCID).[8] However, the precise cause of Nezelof syndrome remains uncertain[3]
In the mechanism of this condition, one first finds that the normal function of the thymus has it being important in T-cell development and release into the body's blood circulation[9] Hassal's corpuscles[10] absence in thymus(atrophy) has an effect on T-cells.[3]
The diagnosis of Nezelof syndrome will indicate a deficiency of T-cells,[11] additionally in ascertaining the condition the following is done:[3][4]
The differential diagnosis for this condition consists of acquired immune deficiency syndrome and severe combined immunodeficiency syndrome[3][8]
In terms of treatment for individuals with Nezelof syndrome, which was first characterized in 1964,[12] includes the following (effectiveness of bone marrow transplant is uncertain[4]) :
Nezelof syndrome diagnosis.